Zoetis

ZTS US Health Care Pharmaceuticals
S&P 500
$72.97
+0.15%
Delayed · cached 15 min

Fair value analysis

ZTS
Zoetis
Health CarePharmaceuticals
$72.97
Close used for this calculation
$114.55Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
78/100
Profitability23/25
Returns19/25
Balance Sheet13/25
Efficiency23/25
Growth20/25
Strong
Quality radar
78Prof.23/25Ret.19/25Eff.23/25B.Sht13/25Growth20/25

Consensus fair value

$114.55
Below FV
▲ +57.0% against the close used
Model range $83.42 – $140.80
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$83.42Fair value$114.55Bull$140.80
FairClose
52-week traded range
52W low $71.8652W high $150.61

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Zoetis closed at $72.97, 36.3% below the consensus fair value of $114.55 drawn from 7 valuation models.

Financial DNA score 78/100 — Strong. P/E of 12.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$102.06
+39.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$120.40
+65.0%
EPS × 20x (sector P/E)
EPS=6.02, Sector P/E=20x
Peter Lynch (PEG)
$97.22
+33.2%
EPS × Growth% (PEG = 1 is fair)
EPS=6.02, g=16.2%
EV/EBITDA
$140.80
+92.9%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=3.85B
Dividend Discount (DDM)
$109.54
+50.1%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=2.03, r=10%, g=8%
Reverse DCF
$72.97
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 0.3% | Historical: 16.2%
Margin of Safety
$83.42
+14.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=111.23, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.